IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
RxPrism Health System Pvt Ltd v Canva Pty Ltd [2023] APO 23
Patent Application: 2020202729
Title:Systems and methods of generating a website
Patent Applicant: Canva Pty Ltd
Opponent: RxPrism Health System Pvt Ltd
Delegate: Leslie F. McCaffery
Decision Date: 1 May 2023
Hearing Date: 9 March 2023 by videoconference and written submissions.
Catchwords: PATENTS – section 223 – opposition to the grant of an extension of time to rely on the grace period prescribed in regulation 2.2C(3) –whether the failure to file within the grace period was an inevitable consequence of the deliberate use of an inadequate system – relevance of previous request for an extension on another application – full and frank disclosure – opposition unsuccessful – costs awarded.
Representation: Counsel for the applicant: Cynthia Cochrane SC
Patent attorney for the applicant: FPA Patent Attorneys Pty Ltd
Patent attorney for the opponent: IP Guardian
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2020202729
Title:Systems and methods of generating a website
Patent Applicant: Canva Pty Ltd
Date of Decision: 1 May 2023
DECISION
The opposition is unsuccessful.
I grant the extension of time of 12 months to file a complete application within the period set out by regulation 2.2C(3).
Costs according to Schedule 8 against the Opponent, RxPrism Health System Pvt Ltd.
REASONS FOR DECISION
The present matter is an opposition to the grant of an extension of time under section 223(2)(a) to file a complete application within the grace period prescribed under section 24(1) and regulation 2.2C(3). The original request was the subject of a decision by a Delegate of the Commissioner in Canva Pty Ltd [2021] APO 35 (Canva). In short, the Delegate, taking all the relevant considerations into account, considered it appropriate to exercise the discretion in the favour of Canva Pty Ltd (the Applicant). They directed that the application for an extension be advertised for opposition purposes. This occurred on 30 September 2021.
A Notice of Opposition was filed by RxPrism Health System Pvt Ltd (the Opponent) on 19 November 2021. A Statement of Grounds and Particulars was filed on 1 December 2021, setting out grounds under sections 223(2)(a), 223(2)(b), 223(2A)(a) and 223(2A)(b). The grounds of opposition under sections 223(2)(b), 223(2A)(a) and 223(2A)(b) were dismissed following a request by the Applicant, but an oppositions delegate considered that a prima facie case had been set out by the Opponent in relation to the ground of opposition under section 223(2)(a).
Both parties filed evidence in the opposition. Evidence in Support (EIS) consisted of a declaration by Dr Maruthi Viswanathan (Viswanathan 1), together with Annexures I to VII. Evidence in Answer (EIA) consisted of a declaration by Mr Kirk Simmons (Simmons 2), together with Annexure B.[1] Evidence in Reply (EIR) consisted of a second declaration by Dr Viswanathan (Viswanathan 2) together with Annexures VIII to XI.
[1] Mr Simmons had previously filed a declaration in support of the request for an extension. Annex…
Keep reading for free
Create a free CaseChat account to read RxPrism Health System Pvt Ltd v Canva Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2023] APO 23
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the court were whether the delay in filing was an inevitable consequence of RxPrism's inadequate system and whether the previous requests for an extension on another application were pertinent to the current dispute. Additionally, the court had to consider whether Canva had made a full and frank disclosure to the relevant authorities, as this would impact the credibility of their application for an extension. The court needed to assess the evidence presented by both parties and determine if the application for an extension should be granted or opposed.
The court found that RxPrism had not demonstrated that the delay in filing was an inevitable consequence of their inadequate system. The court also ruled that the previous requests for an extension on another application were not relevant to the current dispute. Furthermore, the court held that Canva had made a full and frank disclosure to the relevant authorities, which supported their application for an extension. Consequently, the opposition was unsuccessful, and the application for an extension was granted. The court awarded costs to Canva, acknowledging their successful opposition to RxPrism's application.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.